Induction Therapy and Stem Cell Mobilization in Patients with Newly Diagnosed Multiple Myeloma

Table 1

Patients’ characteristics.

Characteristics	Total number of patients	Treated with bortezomib	Treated with lenalidomide	Treated with other agents
Numbers	65	18	18	29
Sex, M/F	44/21	10/8	11/7	23/6
Age
Median (range) years	56.5 (48–65)	56 (48–64)	58 (51–65)	57.5 (50–65)
Monoclonal component
IgG/IgA/κ/λ	37/19/6/3	9/5/1/3	10/6/2/0	18/8/3/0
Durie-Salmon stage
I/II/III	0/5/60	0/0/18	0/2/16	0/3/26
A/B	58/7	14/4	17/1	27/2
ISS stage
1/2/3	20/27/18	6/7/5	8/6/4	6/14/9
Mobilizing chemotherapy
one/two	46/19	13/5	10/8	23/6
Number of leukapheresis
Two/three	31/34	18/0	2/16	11/18